HLA DR+ CD8+ T cells, due to their role in immune responses, particularly in presenting tumor antigens and activating cytotoxic responses, may have a crucial impact on the progression of CLL (56). Here, CD8A is linked to B-cell chronic lymphocytic leukemia.